Rafferty Asset Management, LLC Vericel Corp Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

A detailed history of Rafferty Asset Management, LLC transactions in Vericel Corp stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 53,714 shares of VCEL stock, worth $3.18 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

53,714

Previous 66,116 18.76%

Holding current value

$3.18 Million

Previous $3.03 Million 25.19%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$42.25 - $53.56 $523,984 - $664,251	-12,402 Reduced 18.76%	53,714 $2.27 Million
Q2 2024 Aug 13, 2024	SELL	$41.71 - $52.9 $4.43 Million - $5.62 Million	-106,247 Reduced 61.64%	66,116 $3.03 Million
Q1 2024 May 13, 2024	BUY	$32.52 - $52.33 $2.16 Million - $3.48 Million	66,549 Added 62.89%	172,363 $8.97 Million
Q4 2023 Feb 13, 2024	SELL	$30.85 - $37.09 $599,785 - $721,103	-19,442 Reduced 15.52%	105,814 $3.77 Million
Q3 2023 Nov 13, 2023	BUY	$31.69 - $39.25 $1.01 Million - $1.25 Million	31,863 Added 34.12%	125,256 $4.2 Million
Q2 2023 Aug 11, 2023	SELL	$29.0 - $38.37 $448,804 - $593,814	-15,476 Reduced 14.22%	93,393 $3.51 Million
Q1 2023 May 11, 2023	SELL	$23.85 - $31.34 $1.56 Million - $2.05 Million	-65,370 Reduced 37.52%	108,869 $3.19 Million
Q4 2022 Feb 13, 2023	BUY	$17.65 - $27.37 $586,827 - $909,997	33,248 Added 23.58%	174,239 $4.59 Million
Q3 2022 Nov 14, 2022	BUY	$22.62 - $32.54 $919,819 - $1.32 Million	40,664 Added 40.53%	140,991 $3.27 Million
Q2 2022 Aug 12, 2022	SELL	$22.88 - $39.45 $563,740 - $972,008	-24,639 Reduced 19.72%	100,327 $2.53 Million
Q1 2022 May 13, 2022	SELL	$31.69 - $43.29 $174,326 - $238,138	-5,501 Reduced 4.22%	124,966 $4.78 Million
Q4 2021 Feb 10, 2022	BUY	$35.2 - $52.6 $2.47 Million - $3.69 Million	70,106 Added 116.14%	130,467 $5.13 Million
Q3 2021 Nov 10, 2021	BUY	$46.35 - $59.75 $697,799 - $899,536	15,055 Added 33.23%	60,361 $2.95 Million
Q2 2021 Aug 10, 2021	SELL	$47.2 - $67.81 $1.23 Million - $1.77 Million	-26,069 Reduced 36.52%	45,306 $2.38 Million
Q1 2021 May 10, 2021	BUY	$30.93 - $59.48 $1.62 Million - $3.12 Million	52,417 Added 276.49%	71,375 $3.97 Million
Q4 2020 Feb 10, 2021	SELL	$18.53 - $31.5 $428,191 - $727,902	-23,108 Reduced 54.93%	18,958 $585,000
Q3 2020 Nov 13, 2020	BUY	$14.68 - $19.12 $135,863 - $176,955	9,255 Added 28.21%	42,066 $779,000
Q2 2020 Aug 07, 2020	BUY	$8.5 - $15.82 $278,893 - $519,070	32,811 New	32,811 $453,000
Q1 2020 May 15, 2020	SELL	$7.25 - $19.22 $319,790 - $847,774	-44,109 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$13.77 - $19.2 $776,751 - $1.08 Million	-56,409 Reduced 56.12%	44,109 $767,000
Q3 2019 Nov 14, 2019	BUY	$14.93 - $19.83 $880 - $1,169	59 Added 0.06%	100,518 $1.52 Million
Q2 2019 Aug 09, 2019	BUY	$15.01 - $18.89 $182,446 - $229,607	12,155 Added 13.76%	100,459 $1.9 Million
Q1 2019 May 15, 2019	BUY	$16.23 - $20.29 $1.43 Million - $1.79 Million	88,304 New	88,304 $1.55 Million

Others Institutions Holding VCEL

# of Institutions

276

Shares Held

48.8M

Call Options Held

91.8K

Put Options Held

23.2K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.79B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Vericel Corp Transaction History